8-K: Enhabit Outlines Growth Strategy at Goldman Sachs Healthcare Conference

Enhabit presented its growth strategy focusing on home health and hospice services at the Goldman Sachs 45th Annual Global Healthcare Conference.

Summary

• Enhabit's management participated in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024.
• The company discussed its strategic priorities for 2024, which include stabilizing Medicare revenue, leveraging payor innovation, and growing through increased clinical staffing.
• Enhabit aims to open 10 new de novo locations and ramp up existing ones.
• The company is focused on improving its staffing model, particularly in hospice, and increasing its sales headcount.
• Enhabit is also working to improve its referral to admission process and utilize data analytics to drive high-quality care.
• The company has seen a 29% increase in Medicare Advantage plan enrollment between 2020 and 2023.
• 38% of non-Medicare visits are now under payor innovation contracts with improved rates.
• Enhabit has negotiated 64 new contracts since its spin-off and has a pipeline of 30 new agreements.
• The company expects home health and hospice volumes to grow at midto high-single digits over the next three years.
• De novo locations are expected to have start-up costs of $250K to $350K, with a payback period within two years and reaching run rate within three years.

Sentiment

Score: 7

Explanation: The document presents a positive outlook with clear growth strategies and a focus on operational improvements. While there are some challenges mentioned, the overall tone is optimistic and forward-looking.

Positives

• Enhabit is actively growing its non-Medicare revenue per visit through payor innovation contracts.
• The company has a strong track record of generating free cash flow.
• Enhabit has been consistently recognized as a best place to work.
• The company is focused on improving clinical capacity and payor contracts.
• There is a growing demand for home-based care due to an aging population and consumer preference.
• The company is using technology to optimize clinical resources.
• Enhabit has a strong employee net promoter score.

Negatives

• The company's home health business has historically had a relatively high mix of Medicare business, which is now shifting.
• The company is facing a mix shift impact on the referral source relationship due to the growth in Medicare Advantage elections.
• The company is facing challenges in managing labor and employee benefit costs.

Risks

• The company's ability to execute its strategic plans is subject to various risks and uncertainties.
• Regulatory and other developments impacting the markets for Enhabit's services could affect its performance.
• Changes in reimbursement rates and payment methodologies could impact revenue.
• The company's ability to attract and retain key management personnel and healthcare professionals is crucial.
• Potential disruptions or breaches of information systems could pose a risk.
• The outcome of litigation could impact the company.
• The company's ability to successfully complete and integrate de novo locations, acquisitions, investments, and joint ventures is not guaranteed.
• The company's ability to control costs, particularly labor and employee benefit costs, is a challenge.

Future Outlook

Enhabit expects home health and hospice volumes to grow at midto high-single digits over the next three years. The company also plans to continue investing in de novo locations and improving its staffing model.

Management Comments

• Enhabit's management is focused on stabilizing Medicare revenue and leveraging payor innovation.
• The company is committed to growing through increased clinical staffing and improving its referral to admission process.
• Management believes that upholding their award-winning culture is a key contributor to their continued success.

Industry Context

The presentation highlights Enhabit's focus on adapting to industry trends, such as the increasing enrollment in Medicare Advantage plans and the growing demand for home-based care. The company is positioning itself to capitalize on these trends through payor innovation and strategic growth initiatives.

Comparison to Industry Standards

• Enhabit's traditional Medicare as a percentage of home health revenue is in line with peers.
• The company is actively working to improve its Medicare Advantage rates, which is a common focus in the industry.
• The company's de novo strategy is similar to other healthcare providers looking to expand their reach in attractive markets.
• The company's focus on staffing and employee engagement is consistent with industry best practices.

Stakeholder Impact

• Shareholders can expect potential growth in revenue and profitability.
• Employees will benefit from the company's focus on employee engagement and recognition.
• Patients will benefit from improved access to high-quality home health and hospice services.
• Payors will benefit from improved contract rates and efficient service delivery.

Next Steps

• Enhabit will continue to open new de novo locations.
• The company will focus on improving its staffing model and building its sales headcount.
• Enhabit will continue to negotiate new payor contracts and leverage technology to optimize clinical resources.

Key Dates

Keywords

home health, hospice, Medicare, payor innovation, de novo, clinical staffing, revenue, growth, healthcare, admissions, contracts